Researchers analyzed data from 1,383 adults with a confirmed pulmonary embolism. They looked at the presence of fragmented QRS (fQRS) on an initial heart rhythm test, known as an ECG. This specific finding on the heart's electrical activity was compared to patients who did not have it.
The study found that patients with fragmented QRS had a significantly higher risk of in-hospital mortality and long-term mortality. Additionally, these patients were more likely to experience cardiogenic shock, which is a serious condition where the heart cannot pump enough blood. The study did not find a significant link between the presence of fragmented QRS and the need for more intensive treatments like surgery or mechanical ventilation.
Because this is a meta-analysis of observational data, it shows a link rather than a direct cause. The results are based on studies with moderate to high quality, but there is a possibility of publication bias. Doctors can use this finding as a tool to help identify high-risk patients early. However, it is not a definitive diagnostic tool on its own. Patients should talk to their doctors about how these tests are used to manage their specific care.
Common questions
What is fragmented QRS and how does it affect patients?
Fragmented QRS is a specific finding on an admission ECG, which is a heart rhythm test. In this study of 1,383 adults, patients with this finding showed a higher risk of in-hospital mortality and long-term mortality. It also showed a higher risk for cardiogenic shock. It is used as a marker to help doctors identify patients who may need more intensive management.
Does this finding mean a patient will definitely have a worse outcome?
No, the study shows a link between the finding and higher risks, not a certainty. While the risk of mortality and cardiogenic shock was higher for those with fragmented QRS, the study did not find a significant link to the need for specific treatments like thrombolysis or surgical embolectomy. You should discuss these results with your doctor.
How is this finding used by doctors for treatment?
Because it is a readily available marker on a standard ECG, it can help doctors stratify risk. It may help them identify which patients need more intensive management early on. However, it is not a definitive diagnostic tool, and its role is to help guide clinical decisions for those with a pulmonary embolism.